Home›Companies›Biotech & Pharma›Immunaeon

Immunaeon Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 4, 2023·Suggest an edit

About Immunaeon

Immunaeon is a private company based in Buffalo, New York, incorporated in 2018 in New York. It has reported $250,000 raised in one offering on Form D since April 2023. Its chief executive is Adam Utley.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 23, 2023Apr 4, 2023$250,000target not set1$250KOptions, Simple Agreement for Future EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Immunaeon's Form D filed Apr 4, 2023.

AU
Adam Utley
Chief Executive Officer
DR
Daniel Rera
Chief Operating Officer
JD
Joseph Dinardo
Director of Growth

Sources

  1. SECImmunaeon Inc. filing history